1)  pulomnary masses
肺部肿物
2)  Pulmonary
肺部
1.
The Analysis of CT Manifestations in Pulmonary Inflammatory Pseudotumor;
肺部炎性假瘤CT表现分析
2.
Clinical analysis of recipients of allogeneic hematopoietic stem cell transplantation with a history of pulmonary invasive fungal disease;
伴肺部侵袭性真菌病史的血液病患者行异基因造血干细胞移植的临床分析
3.
The acuquaintance of pulmonary radiographic appearance of malaria;
疟疾的肺部X线征象分析
3)  Lung
肺部
1.
CT Manifestation and Diagnosis of Solitary Inflammatory Nodules of the Lung;
肺部孤立性结节性炎性病变的CT表现及诊断
2.
Clinical value of low-dose lung screening with 16-slice CT scanner in physical examination;
16层螺旋CT低剂量肺部体检的临床应用价值
3.
Clinical observation to the curative effect of nevelbine by comparing with MMC, PDD on the treatment of carcinoma in lung;
诺维本联合MMC、PDD治疗肺部肿瘤32例疗效观察
4)  lungs
肺部
1.
The different atomization insufflation infects the row of phlegm effect influence to the chronic blocking lung disease merge lungs;
氧气间歇雾化吸入法应用于COPD合并肺部感染患者的效果分析
2.
Diagnosis and management of fungal infection of lungs following renal transplantation;
肾移植术后并发肺部真菌感染的诊断和治疗
5)  pulmonary delivery
肺部给药
1.
Preparation of 9-Nitrocamptothecin liposome and its pharmacokinetic after pulmonary delivery to rats;
9-硝基喜树碱脂质体的制备及大鼠肺部给药药动学
2.
Novel technologies and mechanisms of enhancing the bioavailability of protein and peptide drugs through pulmonary delivery;
提高蛋白质及多肽类药物肺部给药生物利用度的方法及其作用机制
3.
OBJECTIVE To prepare artificial pulmonary surfactant(APS)as insulin pulmonary delivery agent.
目的制备人工肺表面活性物质(APS)作为胰岛素(INS)肺部给药载体。
6)  pulmonary drug delivery
肺部给药
1.
Preparation of porous chitosan particles for pulmonary drug delivery;
用于肺部给药的壳聚糖空心微球的制备
2.
Aim To prepare rifapentine(RIF) liposomes modified by surfactants for studying their the water-solubility,drug loading effeciency,release rate and pulmonary drug delivery.
目的制备表面活性剂修饰利福喷丁(R IF)脂质体,进行该脂质体水化性能、载药量、释药速度和肺部给药研究。
3.
Pulmonary drug delivery of liposomes has become one of research foc i in the area of pharmaceutics owing to its specific advantages, such as low irr itation, rapid ab sorption, high bioavailability, satisfactory safety, sustained or controlled rel ease, and so on.
由于脂质体肺部给药具有刺激性小、吸收迅速、生物利用度高、安全性好、可实现持续缓慢释药等独特优势而成为近年来制剂领域的研究热点之一。
参考词条
补充资料:肿物
1.犹言赘瘤。喻多馀无用之物。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。